BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23192362)

  • 1. Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.
    Borghese C; Cattaruzza L; Pivetta E; Normanno N; De Luca A; Mazzucato M; Celegato M; Colombatti A; Aldinucci D
    J Cell Biochem; 2013 May; 114(5):1135-44. PubMed ID: 23192362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.
    Borghese C; Casagrande N; Pivetta E; Colombatti A; Boccellino M; Amler E; Normanno N; Caraglia M; De Rosa G; Aldinucci D
    Oncotarget; 2017 Jun; 8(26):42926-42938. PubMed ID: 28477013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells.
    De Luca A; Gallo M; Aldinucci D; Ribatti D; Lamura L; D'Alessio A; De Filippi R; Pinto A; Normanno N
    J Cell Physiol; 2011 Aug; 226(8):2131-8. PubMed ID: 21520065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice.
    Angelucci A; Gravina GL; Rucci N; Millimaggi D; Festuccia C; Muzi P; Teti A; Vicentini C; Bologna M
    Endocr Relat Cancer; 2006 Mar; 13(1):197-210. PubMed ID: 16601288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition.
    Mercatali L; La Manna F; Miserocchi G; Liverani C; De Vita A; Spadazzi C; Bongiovanni A; Recine F; Amadori D; Ghetti M; Ibrahim T
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling mechanisms that mediate invasion in prostate cancer cells.
    Bonaccorsi L; Marchiani S; Muratori M; Carloni V; Forti G; Baldi E
    Ann N Y Acad Sci; 2004 Dec; 1028():283-8. PubMed ID: 15650253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.
    Amorino GP; Deeble PD; Parsons SJ
    Oncogene; 2007 Feb; 26(5):745-56. PubMed ID: 16862179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis.
    Normanno N; De Luca A; Aldinucci D; Maiello MR; Mancino M; D'Antonio A; De Filippi R; Pinto A
    Endocr Relat Cancer; 2005 Jun; 12(2):471-82. PubMed ID: 15947117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives for prostate cancer treatment: in vitro inhibition of LNCaP and PC3 cell proliferation by amnion-derived mesenchymal stromal cells conditioned media.
    Rolfo A; Giuffrida D; Giuffrida MC; Todros T; Calogero AE
    Aging Male; 2014 Jun; 17(2):94-101. PubMed ID: 24597941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
    Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
    Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI.
    Lee MJ; Heo SC; Shin SH; Kwon YW; Do EK; Suh DS; Yoon MS; Kim JH
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1869-77. PubMed ID: 23735324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV proteins Tat and Nef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation.
    Beaupere C; Garcia M; Larghero J; Fève B; Capeau J; Lagathu C
    Aging Cell; 2015 Aug; 14(4):534-46. PubMed ID: 25847297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Lipoic acid-induced inhibition of proliferation and met phosphorylation in human non-small cell lung cancer cells.
    Michikoshi H; Nakamura T; Sakai K; Suzuki Y; Adachi E; Matsugo S; Matsumoto K
    Cancer Lett; 2013 Jul; 335(2):472-8. PubMed ID: 23507559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
    Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
    Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors.
    Ren J; Bollu LR; Su F; Gao G; Xu L; Huang WC; Hung MC; Weihua Z
    Prostate; 2013 Sep; 73(13):1453-61. PubMed ID: 23765757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
    Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment.
    Pattarozzi A; Gatti M; Barbieri F; Würth R; Porcile C; Lunardi G; Ratto A; Favoni R; Bajetto A; Ferrari A; Florio T
    Mol Pharmacol; 2008 Jan; 73(1):191-202. PubMed ID: 17959712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
    Peng Y; Li Z; Li Z
    Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.